Eden Research plc (LON:EDEN – Get Free Report)’s stock price traded up 2.8% on Tuesday after an insider bought additional shares in the company. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares traded hands during mid-day trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey bought 540,540 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,902.58).
Eden Research Price Performance
The firm’s fifty day simple moving average is GBX 3.88 and its two-hundred day simple moving average is GBX 4.01. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.25. The firm has a market cap of £19.73 million, a PE ratio of -200.00 and a beta of 0.92.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Further Reading
- Five stocks we like better than Eden Research
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Using the MarketBeat Stock Split Calculator
- What Does the Future Hold for Eli Lilly?
- Learn Technical Analysis Skills to Master the Stock Market
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.